Considering CAR T-cell Therapy in Follicular Lymphoma

from Medical Breakthroughs from Penn Medicine

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Elise Chong, MD Patients with follicular lymphoma who relapse or don’t respond to treatment don’t have many therapeutic options, but a recently FDA-approved CAR T-cell therapy may help change that. Dr. Charles Turck is joined by Dr. Elise Chong from Penn Medicine’s Abramson Cancer Center to explore this new treatment option.

Episode metadata supplied by the publisher feed · Published Sep 30, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Considering CAR T-cell Therapy in Follicular Lymphoma

0:00 10:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Breakthroughs from Penn Medicine?

This episode is 10 minutes long.

When was this Medical Breakthroughs from Penn Medicine episode published?

This episode was published on September 30, 2022.

Can I download this Medical Breakthroughs from Penn Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!